Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Zelixir's New Factory to Revolutionize Natural Fragrance Production with ‘AI+Synthetic Biology’

Read more ››
By: GlobeNewswire - 09 Dec 2024

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Vivoryon Therapeutics N.V.

Taiwan's Products for Modern Households Focus on Customization, Health, and Wellbeing

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

2024 ASH Oral Presentation----Abbisko presents promising preliminary phase 2 study results of pimicotinib in the treatment of Chronic Graft-versus-Host Disease (cGvHD) at the 66th ASH Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

AnX Robotica awarded Gastrointestinal Endoscopy Products agreement with Premier, Inc.

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

Disc Medicine Presents Positive Updated Results from Phase 1b Trial in Patients with Myelofibrosis (MF) and Anemia in an Oral Presentation at the 66th American Society of Hematology (ASH) Annual Meeting

Read more ››
By: GlobeNewswire - 09 Dec 2024
Related companies:  Disc Medicine, Inc.

Encouraging Efficacy and Safety: CStone Presents Latest Clinical Data on CS5001 for Advanced Lymphoma at the 66th ASH Annual Meeting

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  CStone Pharmaceuticals

Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Innovent Biologics (USA), Inc.

AI Tool Fight Health Insurance Goes Viral, Empowering Everyone to Challenge Denied Claims

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024

DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based regimens demonstrate improved rates of minimal residual disease (MRD) negativity and progression-free survival in patients with newly diagnosed multiple myeloma

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Johnson & Johnson, Inc.

Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH

Read more ››
By: PR Newswire Association LLC. - 09 Dec 2024
Related companies:  Jacobio Pharmaceuticals

SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate's Dual Mechanism of Action

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  SK Life Science, Inc.

AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients

Read more ››
By: PR Newswire Association LLC. - 08 Dec 2024
Related companies:  AbbVie Inc.

Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Genmab A/S

DARZALEX® (daratumumab) subcutaneous formulation shows 51 percent reduction in risk of progression to active multiple myeloma for patients with high-risk smouldering multiple myeloma

Read more ››
By: GlobeNewswire - 08 Dec 2024

Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Affimed N.V

Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Cogent Biosciences, Inc.

Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  Novartis AG | Novan, Inc.

Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma

Read more ››
By: GlobeNewswire - 08 Dec 2024
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche Ltd | Hoffmann-La Roche Ltd. (Edmonton)
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »